Syndax Pharmaceuticals, Inc. (SNDX) is a publicly traded Healthcare sector company. As of September 4, 2026, SNDX trades at $20.58 with a market cap of $1.85B and a P/E ratio of -8.16. SNDX moved -0.58% today. Year to date, SNDX is +1.68%; over the trailing twelve months it is +20.66%. Its 52-week range spans $8.58 to $25.59. Analyst consensus is strong buy with an average price target of $37.33. Rallies surfaces SNDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for SNDX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $20.58 |
| Market Cap | $1.85B |
| P/E Ratio | -8.16 |
| EPS | $-2.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.59 |
| 52-Week Low | $8.58 |
| Volume | 948.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $252.25M |
| Net Income | $-220.76M |
| Gross Margin | 0.00% |
10 analysts cover SNDX: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $37.33.